Literature DB >> 24698853

Prevalence, awareness, treatment, and control of hypertension in China: results from a national survey.

Jinwei Wang1, Luxia Zhang2, Fang Wang1, Lisheng Liu3, Haiyan Wang2.   

Abstract

BACKGROUND: Hypertension is one of the major risk factor for cardiovascular disease worldwide. The objective of this study was to investigate the prevalence, awareness, treatment, and control of hypertension in China.
METHODS: A multistage, stratified sampling method was used to obtain a representative sample of persons aged 18 years or older in the general population of China. Blood pressure (BP) was measured by sphygmomanometer 3 times at 5-minute intervals. Hypertension was defined as a systolic BP ≥ 140mm Hg, or diastolic BP ≥ 90mm Hg, or self-reported use of antihypertensive medications in the last 2 weeks irrespective of the BP.
RESULTS: Altogether 50,171 subjects finished the survey across the entire country. The adjusted prevalence of hypertension was 29.6% (95% confidence interval (CI) = 28.9%-30.4%) and was higher among men than among women (31.2%, 95% CI = 30.1%-32.4%; vs. 28.0%, 95% CI = 27.0%-29.0%). The awareness, treatment among all hypertensive participants, control among all hypertensive participants, and control among treated hypertensive participants were 42.6%, 34.1%, 9.3%, and 27.4%, respectively. Multiple lifestyle factors were independently associated with presence of hypertension, including physical inactivity, habitual drinking, chronic use of nonsteroidal anti-inflammatory drugs, high body mass index, and central obesity.
CONCLUSIONS: Hypertension is an important public health burden in China, and control of hypertension is still suboptimal. Several modifiable lifestyle activities were associated with hypertension and thus should be considered potential targets for intervention, with special attention to socioeconomically disadvantaged subpopulations in China. © American Journal of Hypertension, Ltd 2014. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  China; blood pressure; epidemiology; hypertension; prevalence.

Mesh:

Substances:

Year:  2014        PMID: 24698853      PMCID: PMC4263934          DOI: 10.1093/ajh/hpu053

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  24 in total

1.  Prevalence, awareness, treatment, and control of hypertension in china.

Authors:  Dongfeng Gu; Kristi Reynolds; Xigui Wu; Jing Chen; Xiufang Duan; Paul Muntner; Guanyong Huang; Robert F Reynolds; Shaoyong Su; Paul K Whelton; Jiang He
Journal:  Hypertension       Date:  2002-12       Impact factor: 10.190

2.  Global burden of hypertension: analysis of worldwide data.

Authors:  Patricia M Kearney; Megan Whelton; Kristi Reynolds; Paul Muntner; Paul K Whelton; Jiang He
Journal:  Lancet       Date:  2005 Jan 15-21       Impact factor: 79.321

3.  Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004.

Authors:  Kwok Leung Ong; Bernard M Y Cheung; Yu Bun Man; Chu Pak Lau; Karen S L Lam
Journal:  Hypertension       Date:  2006-12-11       Impact factor: 10.190

4.  2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension.

Authors:  Judith A Whitworth
Journal:  J Hypertens       Date:  2003-11       Impact factor: 4.844

5.  Prevalence, awareness, treatment and control of hypertension in adults with diagnosed diabetes: the Fourth Korea National Health and Nutrition Examination Survey (KNHANES IV).

Authors:  H-S Lee; S-S Lee; I-Y Hwang; Y-J Park; S-H Yoon; K Han; J-W Son; S-H Ko; Y G Park; H W Yim; W-C Lee; Y-M Park
Journal:  J Hum Hypertens       Date:  2012-12-06       Impact factor: 3.012

6.  Hypertension prevalence and status of awareness, treatment and control in China.

Authors:  S Tao; X Wu; X Duan; W Fang; J Hao; D Fan; W Wang; Y Li
Journal:  Chin Med J (Engl)       Date:  1995-07       Impact factor: 2.628

7.  [Physical activity status of working time and its change over a ten-year period in Beijing and Guangzhou populations].

Authors:  Gaoqiang Xie; Jinzhuang Mai; Liancheng Zhao; Xiaoqing Liu
Journal:  Wei Sheng Yan Jiu       Date:  2008-01

8.  Prevalence, awareness, treatment, and control of hypertension in China: data from the China National Nutrition and Health Survey 2002.

Authors:  Yangfeng Wu; Rachel Huxley; Liming Li; Vibeke Anna; Gaoqiang Xie; Chonghua Yao; Mark Woodward; Xian Li; John Chalmers; Runlin Gao; Lingzhi Kong; Xiaoguang Yang
Journal:  Circulation       Date:  2008-12-16       Impact factor: 29.690

9.  Adherence to a DASH-style diet and risk of coronary heart disease and stroke in women.

Authors:  Teresa T Fung; Stephanie E Chiuve; Marjorie L McCullough; Kathryn M Rexrode; Giancarlo Logroscino; Frank B Hu
Journal:  Arch Intern Med       Date:  2008-04-14

10.  Drinking and drinking patterns and health status in the general population of five areas of China.

Authors:  Wei Hao; Zhonghua Su; Binglun Liu; Kui Zhang; Hanqing Yang; Shaozhong Chen; Meizi Biao; Chun Cui
Journal:  Alcohol Alcohol       Date:  2004 Jan-Feb       Impact factor: 2.826

View more
  160 in total

1.  Association of obesity categories and high blood pressure in a rural adult Chinese population.

Authors:  Y Zhao; M Zhang; X Luo; L Yin; C Pang; T Feng; Y Ren; B Wang; L Zhang; L Li; H Zhang; X Yang; C Han; D Wu; J Zhou; Y Shen; C Wang; J Zhao; D Hu
Journal:  J Hum Hypertens       Date:  2016-02-25       Impact factor: 3.012

2.  Hypertension prevalence, awareness, treatment, and control in northeast China: a population-based cross-sectional survey.

Authors:  Fu-Liang Zhang; Zhen-Ni Guo; Ying-Qi Xing; Yan-Hua Wu; Hao-Yuan Liu; Yi Yang
Journal:  J Hum Hypertens       Date:  2017-11-27       Impact factor: 3.012

3.  Hypertension Prevalence, Awareness, Treatment, and Control in Selected LMIC Communities: Results From the NHLBI/UHG Network of Centers of Excellence for Chronic Diseases.

Authors:  Vilma E Irazola; Laura Gutierrez; Gerald Bloomfield; Rodrigo M Carrillo-Larco; Prabhakaran Dorairaj; Thomas Gaziano; Naomi S Levitt; J Jaime Miranda; Antonio Bernabe Ortiz; Krisela Steyn; Yangfeng Wu; Denis Xavier; Lijing L Yan; Jiang He; Adolfo Rubinstein
Journal:  Glob Heart       Date:  2016-03

4.  The impact of routine follow-up with health care teams on blood pressure control among patients with hypertension.

Authors:  Hui-Juan Zuo; Ji-Xiang Ma; Jin-Wen Wang; Xiao-Rong Chen; Lei Hou
Journal:  J Hum Hypertens       Date:  2019-01-15       Impact factor: 3.012

5.  The interactions between alcohol consumption and DNA methylation of the ADD1 gene promoter modulate essential hypertension susceptibility in a population-based, case-control study.

Authors:  Liyuan Han; Panpan Liu; Changyi Wang; Qilong Zhong; Rui Fan; Lin Wang; Shiwei Duan; Lina Zhang
Journal:  Hypertens Res       Date:  2015-01-08       Impact factor: 3.872

6.  Association of gene polymorphisms in RANKL/RANK/OPG system with hypertension and blood pressure in Chinese women.

Authors:  P Duan; Z-M Wang; J Liu; L-N Wang; Z Yang; P Tu
Journal:  J Hum Hypertens       Date:  2015-03-26       Impact factor: 3.012

7.  Bioequivalence and Pharmacokinetics of Bisoprolol-Amlodipine 5 mg/5 mg Combination Tablet versus Bisoprolol 5 mg Tablet and Amlodipine 5 mg Tablet: An Open-Label, Randomized, Two-Sequence Crossover Study in Healthy Chinese Subjects.

Authors:  Chaoying Hu; Xiao Hu; Chunhua Wang; Zirun Zhao; Dan Gao; Xiaoping Chen; Dongli Zhou; Yue Huang; Lin Li; Lan Zhang
Journal:  Clin Drug Investig       Date:  2018-12       Impact factor: 2.859

8.  Perspective: time to tackle blood pressure.

Authors:  Walter J Koroshetz
Journal:  Nature       Date:  2014-06-26       Impact factor: 49.962

9.  Effectiveness of Self-Monitoring Blood Pressure in Primary Care: A Randomized Controlled Trial.

Authors:  Wichai Aekplakorn; Paibul Suriyawongpaisal; Rassamee Tansirisithikul; Thida Sakulpipat; Phikul Charoensuk
Journal:  J Prim Care Community Health       Date:  2015-11-16

10.  The Inaugural Elijah B. Saunders Memorial Lecture: The Global Consequences of Hypertension and Related Disparities.

Authors:  George A Mensah
Journal:  Ethn Dis       Date:  2016-07-21       Impact factor: 1.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.